About this Event
Do you want to hear what sector’s most influential thinkers say about strategies for neuroscience treatments and innovations for neurodegenerative diseases, and what the future holds for this field. Here is a taste of the likely topics to be discussed in our unique discussion format with keynote interviews with leaders in the field moderated by our forever curious thought-leader Prof Tony Sedgwick. Here are likely some of the areas we will cover:
1. Strategic Landscape
2. Gene-Therapy & Gene-Editing Advances
3. Stem-Cell & Regenerative Strategies
4. Neuroprosthetics & Brain-Computer Interfaces (BCI)
5. Pharmaceutical Pipeline and where are the opportunities, and what's been invested in.
6. Cross-Cutting Enablers: AI & Computational Biology
7. Global Collaboration, Access & Policy
8. Anticipated Impact on Patient Care
9. Challenges Ahead
10. What's the 10-year Outlook
Chatham House Rules apply - "what goes on in the Forum, stays in the Forum - so to speak!"
Who Should Attend
The #CreativeDisruption Forum is designed for professionals working in life sciences who are driving innovation and growth. It is ideal for:
- Founders and executives of biotech, medtech, and healthtech companies
- R&D and clinical development leaders
- Investors and business strategists in the healthcare sector
- Innovation managers, consultants, and academic partners involved in commercialisation
- Students and early-career researchers interested in understanding how scientific innovation translates into successful business ventures
Schedule:
10.00 - 10.30 – Arrival and Networking
10.30 - 10.55 – Introductions to ARC West London
10.55 - 12.10 – Keynote Sessions - with business leaders, analysts, policy makers and investors
12.10-12.30 – Coffee Break & Networking
12.30 - 13.00 – Keynote Session: Strategies for Innovation Companies
13.00 - 13.30 – Keynote Session: Field Insights from Leading Companies
13.30 - 14.30 – Lunch Break and networking
14.30 - 15.15 – Workshops
15.15 - 15.45 – Workshop Group Leader Presentations
15.45 - 16.00 – Closing with Prof. Tony Sedgwick
Heart of Life Science Innovation at #CreativeDisruption Forum
Each #CreativeDisruption Forum centres on open dialogue, expert insight and interactive discussions, guided by our resident thought leader, Prof. Tony Sedgwick.
Known as the www.ThoughtDisruptor.com, Tony brings extensive experience as a trained pathologist, former Global Head of Clinical Research at Roche AG, and CEO and Chairman across several life science companies. He also draws on his background in psychology and leadership to help participants look at familiar challenges from new angles.
Participants can expect:
• Exchange ideas with peers facing similar strategic and operational issues,
• Gain practical insights from experienced founders and executives,
• Explore actionable approaches to commercialisation and growth,
• Strengthen their professional networks across the UK life sciences community.
The Forum provides a trusted environment to discuss challenges openly, share lessons learned, and explore new ways of driving innovation.
We promise that our #CreativeDisruption Forum will be like no other life sciences event or business network you have experienced. You will be walking out of the session inspired, educated and more connected.
ADMISSION FEE for Service Companies such as CROs, CDMOs, Law Firms and Patent Attorneys, Consultancy Firms = £120 - ALL-INCLUSIVE
ADMISSION FEE for Innovative Emerging Life Science Companies and Independent Consultants = £60
Investors can apply for free entry by writing to [email protected].
Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface. CDD helps scientists register entities, track inventory, manage assay data, capture experiments, calculate Structure-Activity Relationships (SAR), and mine their data for drug candidates. CDD was founded in 2004 and presently serves thousands of researchers doing drug discovery all around the world. Learn more at www.collaborativedrug.com
Event Venue & Nearby Stays
ARC West London, Manbre Road, London, United Kingdom
GBP 60.00 to GBP 120.00
